Trimethoprim-sulfamethoxazole therapy for children with acute osteomyelitis

Pediatric Infectious Disease Journal

Volumn 30, Issue 12, 2011, Pages 1019-1021

  Messina, Allison F ^a   Namtu, Katie ^b   Guild, Michelle ^b   Dumois, Juan A ^a   Berman, David M ^a  

^a Division of Infectious Diseases   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

children; osteomyelitis; trimethoprim sulfamethoxazole

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA MULTIFORME; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NEUTROPENIA; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; RASH; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 81855221741     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31822db658     Document Type: Article

References (28)

1. Gwynne-Jones DP, Stott NS. Community-acquired methicillin-resistant Staphylococcus aureus: a cause of musculoskeletal sepsis in children. J Pediatr Orthop. 1999;19:413-416. (Pubitemid 29214992)
2. Fergie JE, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J. 2001;20:860-863. (Pubitemid 32880320)
3. Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis. 2002;8:602-607. (Pubitemid 34556361)
4. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J. 2004;23:619-624. (Pubitemid 38924885)
5. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178-182. (Pubitemid 32374323)
6. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, et al. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004;23:701-706. (Pubitemid 39063283)
7. Purcell K, Fergie JE. Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J. 2002;21:988-989. (Pubitemid 35176172)
8. Adra M, Lawrence KR. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother. 2004;38: 338-341. (Pubitemid 38112251)
9. Hyun DY, Mason EO, Forbes A, et al. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J. 2009;28:57-59.
10. Szumowski JD, Cohen DE, Kanaya F, et al. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother. 2007;51:423-428. (Pubitemid 46185256)
11. Proctor RA. Role of folate antagonists in the treatment of methicillinresistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:584-593. (Pubitemid 351263501)
12. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992;117:390-398.
13. Euba G, Murillo O, Fernandez-Sabe N, et al. Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. Antimicrob Agents Chemother. 2009;53:2672-2676.
14. Nguyen S, Pasquet A, Legout L, et al. Efficacy and tolerance of rifampicinlinezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Clin Microbiol Infect. 2009;15:1163-1169.
15. Stein A, Bataille JF, Drancourt M, et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother. 1998;42:3086-3091. (Pubitemid 28553722)
16. Toma MB, Smith KM, Martin CA, et al. Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Orthopedics. 2006;29:497-501. (Pubitemid 43984650)
17. Saengnipanthkul S, Pongvivat T, Mahaisavariya B, et al. Co-trimoxazole in the treatment of chronic osteomyelitis. J Med Assoc Thai. 1988;71:186-191.
18. Landrum ML, Conger NG, Forgione MA. Trimethoprim-sulfamethoxazole in the treatment of Stenotrophomonas maltophilia osteomyelitis. Clin Infect Dis. 2005;40:1551-1552. (Pubitemid 40628651)
19. Baraboutis IG, Argyropoulou A, Papastamopoulos V, et al. Primary sternal osteomyelitis caused by Nocardia nova: case report and literature review. Braz J Infect Dis. 2008;12:257-259.
20. Black J, Hunt TL, Godley PJ, et al. Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis. J Infect Dis. 1987;155:968-972. (Pubitemid 17062834)
21. Dunkle LM, Brock N. Long-term follow-up of ambulatory management of osteomyelitis. Clin Pediatr (Phila). 1982;21:650-655. (Pubitemid 12005891)
22. Le CT. Salmonella vertebral osteomyelitis: a case report with literature review. Am J Dis Child. 1982;136:722-724. (Pubitemid 12096966)
23. Shen MW. Diagnostic and therapeutic challenges of childhood brucellosis in a nonendemic country. Pediatrics. 2008;121:e1178-e1183.
24. Wilfert CM. Trimethoprim-sulfamethoxazole in children: pharmacokinetics and clinical studies. J Infect Dis. 1973;128(suppl):613-617.
25. Marks MI, Kazemi M, Hales B, et al. Pharmacokinetic studies of trimethoprim-sulfamethoxazole in children with gastroenteritis. J Infect Dis. 1973;128(suppl):622-625.
26. Ruebner R, Keren R, Coffin S, et al. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics. 2006;117:1210-1215. (Pubitemid 46071514)
27. Yagupsky P, Katz O, Peled N. Antibiotic susceptibility of Kingella kingae isolates from respiratory carriers and patients with invasive infections. J Antimicrob Chemother. 2001;47:191-193. (Pubitemid 32149526)
28. Dubnov-Raz G, Scheuerman O, Chodick G, et al. Invasive Kingella kingae infections in children: clinical and laboratory characteristics. Pediatrics. 2008;122:1305-1309.